# OnCo record panova-3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/panova-3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "panova-3", "NCT03377491" ;
  schema:name "PANOVA-3"@en ;
  schema:description "PANOVA-3 is the trial behind the 2026 approval of a wearable electric-field device for pancreatic cancer, the first new approval in locally advanced disease in decades."@en ;
  schema:url <https://onco.cc/trials/panova-3/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03377491>, <https://doi.org/10.1200/JCO-25-00746> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2018-05-10" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/locally-advanced-pdac/> ;
  onco:technologies <https://onco.cc/technologies/ttfields/> ;
  onco:drugs <https://onco.cc/drugs/optune/>, <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> ;
  onco:companies <https://onco.cc/companies/novocure/> ;
  onco:trials <https://onco.cc/trials/mpact/>, <https://onco.cc/trials/lap07/>, <https://onco.cc/trials/conko-007/> .